FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2072774301> ?p ?o ?g. }

• W2072774301 endingPage "647" @default.
• W2072774301 startingPage "642" @default.
• W2072774301 abstract "Vasopressin (AVP) is a hormone with antidiuretic properties that is also involved in cellular proliferation of breast, pulmonary, and pancreatic neoplasias, attributable to the interaction with specific receptors, among which is the V2-R. Using a culture model of CAKI-2 and A498 cancer cells, our study aimed to verify if renal carcinoma cells also express V2-R and whether receptor activation modulates their proliferation. Immunofluorescence and RT-PCR showed that both CAKI-2 and A498 cells effectively synthesize and express the V2-R. Administration of the vasopressin analogue DDAVP induced an evident growth in both CAKI-2 and A498 cell lines. However, this proliferative effect was completely avoided by the preventive addition of the V2-R antagonist SR121463B (satavaptan). Our study shows for the first time that renal cancer may effectively synthesize and express the V2-R. Furthermore, AVP exerts in vitro a proliferative effect by acting on this receptor, as the selective V2-R blockage is able to completely prevent the cellular growth. A validation of these findings with in vivo models is required to ascertain if the eventual presence of V2-R could influence the aggressiveness of human renal neoplasias. From this point of view, a new, interesting therapeutical application of V2-R antagonists in the treatment of renal cancer could also be proposed, similar to that successfully described in the treatment of autosomal polycystic kidney disease (ADPKD)." @default.
• W2072774301 created "2016-06-24" @default.
• W2072774301 creator A5003299264 @default.
• W2072774301 creator A5024487207 @default.
• W2072774301 creator A5030116236 @default.
• W2072774301 creator A5042322517 @default.
• W2072774301 creator A5047669156 @default.
• W2072774301 creator A5048360336 @default.
• W2072774301 creator A5049998360 @default.
• W2072774301 creator A5059481316 @default.
• W2072774301 creator A5059888959 @default.
• W2072774301 creator A5061743795 @default.
• W2072774301 creator A5069363469 @default.
• W2072774301 creator A5080523532 @default.
• W2072774301 creator A5086504590 @default.
• W2072774301 date "2010-11-01" @default.
• W2072774301 modified "2023-10-16" @default.
• W2072774301 title "Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R)" @default.
• W2072774301 cites W1979550434 @default.
• W2072774301 cites W1997803822 @default.
• W2072774301 cites W2009290560 @default.
• W2072774301 cites W2009318525 @default.
• W2072774301 cites W2013620388 @default.
• W2072774301 cites W2030349195 @default.
• W2072774301 cites W2041546338 @default.
• W2072774301 cites W2043524463 @default.
• W2072774301 cites W2044594844 @default.
• W2072774301 cites W2050142735 @default.
• W2072774301 cites W2062555123 @default.
• W2072774301 cites W2065603011 @default.
• W2072774301 cites W2067921628 @default.
• W2072774301 cites W2071867967 @default.
• W2072774301 cites W2085580830 @default.
• W2072774301 cites W2086215320 @default.
• W2072774301 cites W2147439250 @default.
• W2072774301 cites W2159014350 @default.
• W2072774301 cites W2166176682 @default.
• W2072774301 cites W2184873303 @default.
• W2072774301 cites W4236869732 @default.
• W2072774301 cites W4242549075 @default.
• W2072774301 doi "https://doi.org/10.1016/j.urolonc.2008.12.014" @default.
• W2072774301 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19217806" @default.
• W2072774301 hasPublicationYear "2010" @default.
• W2072774301 type Work @default.
• W2072774301 sameAs 2072774301 @default.
• W2072774301 citedByCount "18" @default.
• W2072774301 countsByYear W20727743012012 @default.
• W2072774301 countsByYear W20727743012013 @default.
• W2072774301 countsByYear W20727743012014 @default.
• W2072774301 countsByYear W20727743012015 @default.
• W2072774301 countsByYear W20727743012016 @default.
• W2072774301 countsByYear W20727743012017 @default.
• W2072774301 countsByYear W20727743012018 @default.
• W2072774301 countsByYear W20727743012019 @default.
• W2072774301 countsByYear W20727743012020 @default.
• W2072774301 countsByYear W20727743012021 @default.
• W2072774301 countsByYear W20727743012022 @default.
• W2072774301 countsByYear W20727743012023 @default.
• W2072774301 crossrefType "journal-article" @default.
• W2072774301 hasAuthorship W2072774301A5003299264 @default.
• W2072774301 hasAuthorship W2072774301A5024487207 @default.
• W2072774301 hasAuthorship W2072774301A5030116236 @default.
• W2072774301 hasAuthorship W2072774301A5042322517 @default.
• W2072774301 hasAuthorship W2072774301A5047669156 @default.
• W2072774301 hasAuthorship W2072774301A5048360336 @default.
• W2072774301 hasAuthorship W2072774301A5049998360 @default.
• W2072774301 hasAuthorship W2072774301A5059481316 @default.
• W2072774301 hasAuthorship W2072774301A5059888959 @default.
• W2072774301 hasAuthorship W2072774301A5061743795 @default.
• W2072774301 hasAuthorship W2072774301A5069363469 @default.
• W2072774301 hasAuthorship W2072774301A5080523532 @default.
• W2072774301 hasAuthorship W2072774301A5086504590 @default.
• W2072774301 hasConcept C121608353 @default.
• W2072774301 hasConcept C126322002 @default.
• W2072774301 hasConcept C134018914 @default.
• W2072774301 hasConcept C150903083 @default.
• W2072774301 hasConcept C170493617 @default.
• W2072774301 hasConcept C202751555 @default.
• W2072774301 hasConcept C20352681 @default.
• W2072774301 hasConcept C207001950 @default.
• W2072774301 hasConcept C2776370428 @default.
• W2072774301 hasConcept C2776885963 @default.
• W2072774301 hasConcept C2779420931 @default.
• W2072774301 hasConcept C502942594 @default.
• W2072774301 hasConcept C55493867 @default.
• W2072774301 hasConcept C62112901 @default.
• W2072774301 hasConcept C71924100 @default.
• W2072774301 hasConcept C86803240 @default.
• W2072774301 hasConcept C90474776 @default.
• W2072774301 hasConcept C96232424 @default.
• W2072774301 hasConceptScore W2072774301C121608353 @default.
• W2072774301 hasConceptScore W2072774301C126322002 @default.
• W2072774301 hasConceptScore W2072774301C134018914 @default.
• W2072774301 hasConceptScore W2072774301C150903083 @default.
• W2072774301 hasConceptScore W2072774301C170493617 @default.
• W2072774301 hasConceptScore W2072774301C202751555 @default.
• W2072774301 hasConceptScore W2072774301C20352681 @default.
• W2072774301 hasConceptScore W2072774301C207001950 @default.

• next